Principles of surfactant replacement

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1408, Issue 2-3, 1998, Pages 346-361

  Robertson, Bengt ^a   Halliday, Henry L ^b  

^a Div for Exp Perinatal Pathology   (Sweden)

^b ROYAL MATERNITY HOSPITAL   (United Kingdom)

Author keywords

Clinical trial; Meconium aspiration; Pneumonia; Pulmonary surfactant; Respiratory distress syndrome; Surfactant protein

Indexed keywords

LUNG SURFACTANT; SURFACTANT;

AEROSOL; ANIMAL EXPERIMENT; ANIMAL MODEL; CONTROLLED STUDY; ENDOTRACHEAL TUBE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG ALVEOLUS; MECONIUM ASPIRATION; NEONATAL RESPIRATORY DISTRESS SYNDROME; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; REVIEW;

BIOLOGICAL PRODUCTS; GLYCOPROTEINS; HUMANS; INFANT, NEWBORN; PHOSPHOLIPIDS; PROTEOLIPIDS; PULMONARY SURFACTANTS; RANDOMIZED CONTROLLED TRIALS; RESPIRATORY DISTRESS SYNDROME, NEWBORN;

ANIMALIA; MAMMALIA; OVIS ARIES;

EID: 0031772194     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0925-4439(98)00080-5     Document Type: Review

References (72)

1. Gruenwald P. Surface tension as a factor in the resistance of neonatal lungs to aeration. Am. J. Obstet. Gynecol. 53:1947;996-1007.
2. B. Robertson, Experimental models for evaluation of exogenous surfactants, in: B. Robertson, H.W. Taeusch (Eds.), Surfactant Therapy for Lung Disease. Marcel Dekker, New York, 1995, pp. 239-267.
3. Fujiwara T., Maeta H., Chida S., Morita T., Watabe Y., Abe T. Artificial surfactant therapy in hyaline-membrane disease. Lancet. 1:1980;55-59.
4. K.M.W. Keough, Physical chemistry of pulmonary surfactant in the terminal air spaces, in: B. Robertson, L.M.G. van Golde, J.J. Batenburg (Eds.), Pulmonary Surfactant: From Molecular Biology to Clinical Practice, Elsevier, Amsterdam, 1992, pp. 109-164.
5. S. Schürch, H. Bachofen, Basic physiological and biochemical aspects of surfactant function, in: B. Robertson, H.W. Taeusch (Eds.), Surfactant Therapy for Lung Disease, Marcel Dekker, New York, 1995, pp. 3-32.
6. A.H. Jobe, E.D. Rider, Catabolism and recycling of surfactant, in: B. Robertson, L.M.G. van Golde, J.J. Batenburg (Eds.), Pulmonary Surfactant: From Molecular Biology to Clinical Practice, Elsevier, Amsterdam, 1992, pp. 313-337.
7. T. Fujiwara, B. Robertson, Pharmacology of exogenous surfactant, in: B. Robertson, L.M.G. van Golde, J.J. Batenburg (Eds.), Pulmonary Surfactant: From Molecular Biology to Clinical Practice, Elsevier, Amsterdam, 1992, pp. 561-592.
8. Kobayashi T., Nitta K., Takahashi R., Kurashima K., Robertson B., Suzuki Y. Activity of pulmonary surfactant after blocking the associated SP-A and SP-B proteins. J. Appl. Physiol. 71:1991;530-536.
9. Tanaka Y., Takei T., Aiba T., Masuda K., Kiuchi A., Fujiwara T. Development of synthetic lung surfactants. J. Lipid Res. 27:1986;475-485.
10. Oosterlaken-Dijksterhuis M.A., Haagsman H.P., van Golde L.M.G., Demel R.A. Characterization of lipid insertion into monomolecular layers mediated by lung surfactant proteins SP-B and SP-C. Biochemistry. 30:1991;8276-8287.
11. Yukitake K., Brown C.L., Schluether M.A., Clements J.A., Hawgood S. Surfactant apoprotein A modifies the inhibitory effect of plasma proteins on surfactant activity in vivo. Pediatr. Res. 37:1995;21-25.
12. Ikegami M., Ueda T., Absolom D., Baxter C., Rider E., Jobe A.H. Changes in exogenous surfactant in ventilated preterm lamb lungs. Am. Rev. Respir. Dis. 148:1993;837-844.
13. Pettenazzo A., Jobe A., Ikegami M., Seidner S. Clearance of treatment doses of surfactant. Effect of lipid extraction and aggregate sizes. Biol. Neonate. 53:1988;23-31.
14. Hallman M., Merritt T.A., Bry K. The fate of exogenous surfactant in neonates with respiratory distress syndrome. Clin. Pharmacokinet. 26:1994;215-232.
15. Jobe A., Ikegami M. Surfactant for the treatment of respiratory distress syndrome. Am. Rev. Respir. Dis. 136:1987;1256-1275.
16. Hallman M., Merritt T.A., Pohjavuori M., Gluck L. Effect of surfactant substitution on lung effluent phospholipids in respiratory distress syndrome: evaluation of surfactant phospholipid turnover, pool size, and the relationship to severity of respiratory failure. Pediatr. Res. 20:1986;1228-1235.
17. Metcalfe I.L., Pototschnik R., Burgoyne R., Enhorning G. Lung expansion and survival in rabbit neonates treated with surfactant extract. J. Appl. Physiol. 53:1982;838-843.
18. B. Disse, L. Gortner, E. Weller, H. Eberhardt, H. Ziegler, Efficacy and standardisation of SF-R1: a preparation from bovine lung surfactant, in: B. Lachmann (Ed.), Surfactant Replacement Therapy in Neonatal and Adult Respiratory Distress Syndrome, Springer-Verlag, Berlin, 1988, pp. 37-41.
19. Ogawa A., Brown C.L., Schlueter M.A., Benson B.J., Clements J.A., Hawgood S. Lung function, surfactant apoprotein content, and level of PEEP in prematurely delivered rabbits. J. Appl. Physiol. 77:1994;1840-1849.
20. Björklund L.J., Ingimarsson J., Curstedt T., John J., Robertson B., Werner O., Vilstrup C.T. Manual ventilation with a few large breaths at birth compromises the therapeutic effect of subsequent surfactant replacement in immature lambs. Pediatr. Res. 42:1997;348-355.
21. Wada K., Jobe A.H., Ikegami M. Tidal volume effects on surfactant treatment responses with the initiation of ventilation in preterm lambs. J. Appl. Physiol. 83:1997;1054-1061.
22. Moses D., Holm B.A., Spitale P., Liu M., Enhorning G. Inhibition of pulmonary surfactant function by meconium. Am. J. Obstet. Gynecol. 164:1991;477-481.
23. Segerer H., van Gelder W., Angenent F.W.M., van Woerkens L.J.P.M., Curstedt T., Obladen M., Lachmann B. Pulmonary distribution and efficacy of exogenous surfactant in lung-lavaged rabbits are influenced by the instillation technique. Pediatr. Res. 34:1993;490-494.
24. Morley C.J., Bangham A.D., Miller N., Davis J.A. Dry artificial lung surfactant and its effect on very premature babies. Lancet. 1:1981;64-68.
25. Ellyett K.M., Roadbent R.S., Fawcett E.R., Campbell A.J. Surfactant aerosol treatment of respiratory distress syndrome in the spontaneously breathing premature rabbit. Pediatr. Res. 39:1996;953-957.
26. Lewis J.F., Ikegami M., Jobe A.H., Tabor B. Aerosolized surfactant treatment of preterm lambs. J. Appl. Physiol. 70:1991;869-876.
27. Lewis J.F., Tabor B., Ikegami M., Jobe A.H., Joseph M., Absolom D. Lung function and surfactant distribution in saline-lavaged sheep given instilled vs. nebulized surfactant. J. Appl. Physiol. 74:1993;1256-1264.
28. Li W.-Z., Chen W.-M., Kobayashi T. Aerosolized surfactant reverses respiratory failure in lung-lavaged rats. Acta Anaesthesiol. Scand. 38:1994;82-88.
29. Dijk P.H., Heikamp A., Piers D.A., Weller E., Oetomo S.B. Surfactant nebulisation - safety, efficiency and influence on surface lowering properties and biochemical composition. Intens. Care Med. 23:1997;456-462.
30. Cosmi E.V., La Torre R., Di Iorio R. Intraamniotic instillation of surfactant for prevention of neonatal respiratory distress syndrome (RDS): a preliminary report. Appl. Cardiopulm. Pathophysiol. 6:1996;3-5.
31. Avery M.E. Unnecessary invasion of fetal privacy. Appl. Cardiopulm. Pathophysiol. 6:1996;1.
32. J.F. van Iwaarden, L.M.G. van Golde, Pulmonary surfactant and lung defense, in: B. Robertson, H.W. Taeusch (Eds.), Surfactant Therapy for Lung Disease, Marcel Dekker, New York, 1995, pp. 75-92.
33. LeVine A.M., Bruno M.D., Huelsman K.M., Ross G.F., Whitsett J.A., Korfhagen T.R. Surfactant protein A-deficient mice are susceptible to group B streptococcal infection. J. Immunol. 158:1997;4336-4340.
34. Herting E., Jarstrand C., Rasool O., Curstedt T., Sun B., Robertson B. Experimental neonatal group B streptococcal pneumonia: Effect of a modified porcine surfactant on bacterial proliferation in ventilated near-term rabbits. Pediatr. Res. 36:1994;784-791.
35. Sherman M.P., Campell L.A., Merritt T.A., Shapiro D.L., Long W.A., Gunkel J.H., Curstedt T., Robertson B. Effect of different surfactants on pulmonary group B streptococcal infection in premature rabbits. J. Pediatr. 125:1994;939-947.
36. B. Lachmann, G.J. van Daal, Adult respiratory distress syndrome: animal models, in: B. Robertson, L.M.G. van Golde, J.J. Batenburg (Eds.), Pulmonary Surfactant: From Molecular Biology to Clinical Practice, Elsevier, Amsterdam, 1992, pp. 635-663.
37. R.F. Soll, M.C. McQueen, Respiratory distress syndrome, in: J.C. Sinclair, M.B. Bracken (Eds.), Effective Care of the Newborn Infant, Oxford University Press, Oxford, 1992, pp. 325-358.
38. R.F. Soll, C.J. Morley, Prophylactic surfactant vs treatment with surfactant, in: J.C. Sinclair, M.B. Bracken, R.F. Soll, J.D. Horbar (Eds.), Neonatal Module of the Cochrane Database of Systematic Reviews (updated 2 December 1997). Available in The Cochrane Library (database on disk and CD-ROM). The Cochrane Collaboration, Issue 1, Oxford Update Software, 1998, updated quarterly.
39. H.L. Halliday, W.O. Tarnow-Mordi, J.D. Corcoran, C.C. Patterson on behalf of the Collaborative European Multicentre Study Group, A multicentre randomised trial comparing high and low dose surfactant regimens for the treatment of respiratory distress syndrome (The Curosurf 4 trial), Arch. Dis. Child. 66 (1993) 276-280.
40. H. Halliday, C.P. Speer, Strategies for surfactant therapy in established neonatal respiratory distress syndrome, in: B. Robertson, H.W. Taeusch (Eds.), Surfactant Therapy for Lung Disease, Marcel Dekker, New York, 1995, pp. 443-459.
41. The OSIRIS Collaborative Group, Early versus delayed administration of a synthetic surfactant - the judgement of OSIRIS, Lancet 340 (1992) 1363-1369.
42. Dunn M.S., Shennan A.T., Zayack D., Possmayer F. Bovine surfactant replacement therapy in neonates of less than 30 weeks' gestation: a randomised controlled trial of prophylaxis versus treatment. Pediatrics. 87:1991;377-386.
43. Merritt T.A., Hallman M., Berry C., Pohjavuori M., Edwards D.K. III, Jaaskelainen J., Grafe M.R., Vaucher Y., Wozniak P., Heldt G., Rapola J. Randomized, placebo-controlled trial of human surfactant given at birth versus rescue administration in very low birth weight infants with lung immaturity. J. Pediatr. 118:1991;58-94.
44. Kendig J.W., Notter R.H., Cox C., Reubens L.J., Davis J.M., Maniscalco W.M., Sinkin R.A., Bartoletti A., Dweck H.S., Horgan M.J., Risemberg H., Phelps D.L., Shapiro D.L. A comparison of surfactant as immediate prophylaxis and as rescue therapy in newborns of less than 30 weeks gestation. N. Engl. J. Med. 324:1991;865-871.
45. Egberts J., Brand R., Walti H., Bevilacqua G., Bréart G., Gardini F. Mortality, severe respiratory distress syndrome, and chronic lung disease of the newborn are reduced more after prophylactic than after therapeutic administration of the surfactant Curosurf. Pediatrics. 100:1997;E41-E46.
46. Morley C.J. Systematic review of prophylactic vs rescue surfactant. Arch. Dis. Child. 77:1997;F70-F74.
47. H.L. Halliday, Prophylactic surfactant for preterm infants, in: F. Cockburn (Ed.), Advances in Perinatal Medicine, Parthenon Press, Lancaster, 1997, pp. 360-370.
48. J.D. Horbar, L.L. Wright, R.F. Soll, E.C. Wright, A.A. Fanaroff, S.B. Korones, S. Shankaran, W. Oh, B.D. Fletcher, C.R. Bauer, J.E. Tyson, J.A. Lemons, E.F. Donovan, B.J. Stoll, D.D. Stevenson, L.-A. Papile, J. Philips III for the National Institute of Child Health and Human Development Neonatal Research Network, A multicenter randomized trial comparing two surfactants for the treatment of neonatal respiratory distress syndrome, J. Pediatr. 123 (1993) 757-766.
49. Vermont-Oxford Neonatal Network, A multicenter randomized trial comparing synthetic surfactant with modified bovine surfactant extract in the treatment of neonatal respiratory distress syndrome, Pediatrics 97 (1996) 1-6.
50. Halliday H.L. Natural vs synthetic surfactants in neonatal respiratory distress syndrome. Drugs. 51:1996;226-237.
51. R.F. Soll, Natural surfactant extract vs synthetic surfactant in the treatment of established respiratory distress syndrome, in: J.C. Sinclair, M.B. Bracken, R.F. Soll, J.D. Horbar (Eds.), Neonatal Module of the Cochrane Database of Systematic Reviews (updated 2 December 1997). Available in the Cochrane Library (database on disk and CD-ROM). The Cochrane Collaboration, Issue 1, Oxford, Update Software, 1998, updated quarterly.
52. Victorin L.H., Deverajan L.V., Curstedt T., Robertson B. Surfactant replacement in spontaneously breathing babies with hyaline membrane disease - a pilot study. Biol. Neonate. 58:1990;121-126.
53. H. Verder, B. Robertson, G. Greisen, F. Ebbesen, P. Albertsen, K. Lundstrom, T. Jacobsen for the Danish-Swedish Multicenter Study Group, Surfactant therapy and nasal continuous positive airway pressure for newborns with respiratory distress syndrome, N. Engl. J. Med. 331 (1994) 1051-1055.
54. D. Stevenson, F. Walther, W. Long, M. Sell, T. Pauly, A. Gong, D. Easa, A. Pramanik, M. LeBlanc, E. Anday, R. Dhanireddy, D. Burchfield, A. Corbet and the American Exosurf Neonatal Study Group I, Controlled trial of a single dose of synthetic surfactant at birth in premature infants weighing 500-699 grams, J. Pediatr. 120 (1992) S3-S12.
55. Svenningsen N.W., Saugstad O.D. Surfactant treatment of extremely low birth weight (ELBW) infants. Appl. Cardiopulm. Pathophysiol. 6:1996;11-17.
56. Ferrara T.B., Hoekstra R.E., Couser R.J., Gaziano E.P., Calvin S.E., Payne N.R., Fangman J.J. Survival and follow-up of infants born at 23 to 26 weeks of gestational age: effects of surfactant therapy. J. Pediatr. 124:1994;119-124.
57. Findlay R.D., Taeusch H.W., Walther F.J. Surfactant replacement therapy for meconium aspiration syndrome. Pediatrics. 97:1996;48-52.
58. Spragg R.G., Gilliard N., Richman P., Smith R.M., Hite R.D., Pappert D., Robertson B., Curstedt T. Acute effects of a single dose of porcine surfactant on patients with the adult respiratory distress syndrome. Chest. 105:1994;195-202.
59. Anzueto A., Baughman R., Gantupalli K.K., Weg J.G., Wiedemann H.P., Raventos A.A., Lemaire F., Long W., Zaccardelli D.A., Pattishall E.N. Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. New Engl. J. Med. 334:1996;1417-1421.
60. Gregory T.J., Steinberg K.P., Spragg R., Gadek J.E., Hyers T.M., Longmore W.J., Moxley M.A., Cai G.-Z., Hite R.D., Smith R.M., Hudson L.D., Crim C., Newton P., Mitchell B.R., Gold A.J. Bovine surfactant therapy for patients with acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 155:1997;1309-1315.
61. Dargaville P.A., South M., McDougall P.N. Surfactant abnormalities in infants with severe viral bronchiolitis. Arch. Dis. Child. 75:1996;133-136.
62. Luchetti M., Casiraghi G., Valseechi R., Galassini E., Marraro G. Porcine-derived surfactant treatment of severe bronchiolitis. Acta Anaesthesiol. Scand. 42:1998;805-810.
63. Anzueto A., Jubran A., Ohar J.A., Piquette C.A., Rennard S.I., Colice G., Pattishall E.N., Barrett J., Engle M., Perret K.A., Rubin B.K. Effects of aerosolized surfactant in patients with stable chronic bronchitis. J. Am. Med. Assoc. 278:1997;1426-1431.
64. Nogee L.M., de Mello D.E., Dehner L.P., Colten H.R. Deficiency of pulmonary surfactant protein B in congenital alveolar proteinosis. New Engl. J. Med. 328:1993;406-410.
65. Hamvas A., Cole S., de Mello D.E., Moxley M., Whitsett J.A., Colten H.R., Nogee L.M. Surfactant protein B deficiency: antenatal diagnosis and prospective treatment with surfactant replacement. J. Pediatr. 125:1994;356-361.
66. J.D. Horbar, E.C. Wright, L. Onstad and members of the National Institute of Child Health and Human Development Neonatal Research Network, Decreasing mortality associated with the introduction of surfactant therapy: an observational study of neonates weighing 601 to 1300 grams at birth, Pediatrics 92 (1993) 191-196.
67. Wegman M.E. Annual summary of vital statistics - 1993. Pediatrics. 94:1994;792-803.
68. Egberts J. Theoretical changes in neonatal hospitalization costs after the introduction of porcine-derived lung surfactant ('Curosurf'). PharmacoEconomics. 8:1995;324-342.
69. Hawgood S., Ogawa A., Yukitake K., Schlueter M., Brown C., White T., Buckley D., Lesikar D., Benson B. Lung function in premature rabbits treated with recombinant human surfactant protein-C. Am. J. Respir. Crit. Care Med. 154:1996;484-490.
70. Cochrane C.G., Revak S.D. Pulmonary surfactant protein B (SP-B): structure-function relationship. Science. 254:1991;566-568.
71. 4-surfactant in preterm infants with respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 153:1996;404-410.
72. F.J. Walther, Surfactant therapy for neonatal lung disorders other than respiratory distress syndrome, in: B. Robertson, H.W. Taeusch (Eds.), Surfactant Therapy for Lung Disease, Marcel Dekker, New York, 1995, pp. 461-476.